Akebia Therapeutics, Inc. logo AKBA - Akebia Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 7
HOLD 3
SELL 1
STRONG
SELL 0
| PRICE TARGET: $4.00 DETAILS
HIGH: $4.00
LOW: $4.00
MEDIAN: $4.00
CONSENSUS: $4.00
UPSIDE: 292.16%

Profitability Ratios

Ratio Value
GP Margin 83.3%
EBIT Margin 8.7%
EBITDA Margin 9.2%
Operating Margin 9.9%
Pretax Margin -1.6%
Cont. Ops Margin -2.3%
Net Margin -2.3%
Bottom Line Margin -2.3%

Liquidity Ratios

Ratio Value
Current Ratio 1.13
Quick Ratio 1.04
Solvency Ratio -0.012
Cash Ratio 1.13

Valuation Ratios

Ratio Value
Price/Earnings
-77.46
Peers avg: 17.5
PEG Ratio 0.83
Forward PEG 0.83
Price/Book 12.70
Price/Sales 1.75
Price/FCF 6.09
Price/Op Cash Flow 6.09

Debt Ratios

Ratio Value
Debt/Assets 0.5744
Debt/Equity 6.6329
Debt/Capital 0.8690
Long-Term Debt/Capital 0.8438
Financial Leverage 11.55

Cash Flow Ratios

Ratio Value
Working Capital Turnover 8.62
Operating Cash Flow Ratio 0.417
Operating Cash Flow/Sales 28.8%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.31
Interest Coverage 0.9719
Short-Term Operating Cash Flow Coverage 1.70
Operating Cash Flow Coverage 0.31
Capital Expenditure Coverage 233.65
Dividend + Capital Expenditure Coverage 233.65

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.92
EPS -0.021
Debt/Share 0.9351
Cash/Share 0.72
Book Value/Share 0.13
Tangible BV/Share -0.10
Equity/Share 0.13
Operating Cash Flow/Share 0.264
Capital Expenditure/Share 0.001
FCF/Share 0.264

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.436
Earnings Before Tax/EBIT -0.158
Price/Fair Value 12.70
Debt/Market Cap 0.5224
Effective Tax Rate -43.6%
Enterprise Value Multiple 20.50